Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology - ScienceDirect
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology - ScienceDirect,Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration | Cancer Immunology, Immunotherapy,The therapeutic potential of RNA m(6)A in lung cancer | Cell Communication and Signaling | Full Text,Lords of the Mountains | Heidelberg University Publishing,Comparing the compositions and influence of aerosol particles retained on trees, shrubs, and herbs - ScienceDirect